Accession Number: | 0001628280-21-012283 |
Date: | 2021-06-11 |
Issuer: | ARENA PHARMACEUTICALS INC (ARNA) |
Original Submission Date: |
GALLAHUE KIERAN
6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-11 | A | 3,067 | a | $0.00 | 9,283 | direct | ||
COMMON STOCK | 2021-06-11 | 0 | $0.00 | 3,628 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 65.19 | 2021-06-11 | deemed execution date | A | 7,202 (a) | 2028-06-11 | common stock 7,202 | $65.19 | 7,202 | direct |
ID | footnote |
---|---|
f1 | the amount represents restricted stock units that vest in full on the earliest of june 11, 2022, or the date of arena's next annual meeting of stockholders. the shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units. |
f2 | the options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on july 11, 2021 with the final installment vesting upon the earlier of the one-year anniversary of the grant date or the date of the next annual stockholders' meeting, and are exercisable once vested. |